Investor Relations & Growth Opportunities

Explore SINC’s Financial Performance, Strategic Vision, and Investment Opportunities.

About Sincerity Applied Materials Holdings Corp

Commercializing SpectroVera | OTC: SINC

Sincerity Applied Materials Holdings Corporation (“SINC”) is a Nevada corporation with its principal operations in Australia. The Company is focused on developing and commercializing advanced materials and water-treatment technologies designed to address demanding industrial and environmental applications.

SINC’s primary strategic objective is the commercialization of SpectroVera, its advanced-materials technology platform. SpectroVera builds on the Company’s work in engineered nanoporous glass, surface functionalization and high-performance filtration media. The technology is being developed for applications that may include water treatment, industrial filtration, antimicrobial materials, catalysis and environmental remediation.

Alongside its advanced-materials program, SINC maintains an operating foundation in water-treatment chemicals and related products. These activities provide industry experience, customer relationships, supply-chain capabilities and a practical commercial channel through which the Company can support the market introduction of new treatment technologies.

SINC is preparing a private placement of up to $10 million, through separate Regulation D and Regulation S pathways, principally to fund the commercialization of SpectroVera. Subject to definitive offering documents and Company approval, the financing is expected to support commercial-scale development, product validation, manufacturing preparation, intellectual-property protection, market development, customer qualification and working capital.

Following completion of the financing, SINC intends to promptly commence its formal program to pursue an uplisting to the New York Stock Exchange. This process is expected to include financial, governance, audit, regulatory and listing preparations required under the applicable NYSE listing standard.

SINC’s strategy is to combine its applied-materials expertise, water-treatment operating experience and public-company structure to advance SpectroVera from technology development toward commercial deployment, customer adoption and long-term value creation.

SINC’s common stock is currently quoted through OTC Markets under the symbol SINC. Certain broker-dealers may impose electronic trading restrictions or other limitations affecting market access. The Company has therefore elected not to depend on current secondary-market trading as the principal source of capital for SpectroVera’s commercialization.

The proposed private placement, use of proceeds and NYSE uplisting program remain subject to final documentation, applicable securities laws, Company approval and professional advice. An NYSE uplisting will also depend on SINC satisfying the applicable listing standards and completing the required regulatory and exchange reviews; there can be no assurance that an uplisting will be completed.

SINC Capital Markets Roadmap

As of November 2026

Sincerity Applied Materials Holdings Corporation (“SINC” or the “Company”) has reassessed its near-term capital markets strategy in response to continuing electronic trading restrictions imposed by certain broker-dealers.

Based on currently available information, the Company has not identified a reliable or predictable timetable for the removal of these restrictions. Accordingly, SINC has decided not to rely on public-market trading access as its principal method of financing the commercialization of its technology.

SINC is instead preparing a private placement of up to $10 million under separate Regulation D and Regulation S pathways. The principal purpose of the financing is to advance the commercial launch and market development of SpectroVera.

Upon completion of the financing, SINC intends to promptly commence its formal NYSE uplisting program.

Private Placement Capital Strategy

SINC is preparing a private placement financing of up to:

  • $10,000,000 in aggregate proceeds

  • Up to 20,000,000 shares

  • Proposed price: $0.50 per share

The financing is expected to be conducted through two separate, legally compliant pathways:

  • Regulation D for eligible U.S. investors

  • Regulation S for eligible investors located outside the United States

All proposed terms remain subject to final Company approval, definitive offering documents and advice from SINC’s legal and professional advisers.

Primary objective: Commericalization of SpectroVera

The primary purpose of the financing is to fund the commercialization of SpectroVera, SINC’s advanced materials technology platform.

Subject to the final business plan and offering documents, proceeds are expected to support:

  • Commercial-scale development and production readiness

  • Product validation, testing and customer qualification

  • Intellectual-property development and protection

  • Manufacturing and supply-chain preparation

  • Commercial partnerships and market development

  • Sales, marketing and customer acquisition

  • Technical, operational and working-capital requirements

  • Professional, regulatory and capital-markets expenses

SINC’s objective is to move SpectroVera from its current development stage toward commercial deployment, customer adoption and revenue generation.

Disclaimer

The Company’s uplisting roadmap is contingent on meeting regulatory, financial, and operational requirements, and no assurance can be given that any uplisting will be completed within a specific timeframe.

The information presented on this page is for general informational purposes only and does not constitute investment advice, an offer to sell securities, or a solicitation to purchase any securities of Sincerity Applied Materials (SINC) or its affiliates.

SINC does not provide financial, legal, or tax advice. Any reference to the company’s products, technology, potential market applications, or future plans is strictly informational and should not be interpreted as a forecast of financial performance or a guarantee of future results.

Investing in publicly traded securities involves risk, including the possible loss of principal. Prospective investors should conduct their own independent research, consult licensed financial advisers, and review all publicly available filings on OTC Markets or the SEC’s EDGAR system before making any investment decision.

Any past performance or market commentary is not indicative of future results. SINC makes no warranties, express or implied, regarding the accuracy or completeness of the information provided on this landing page, and assumes no liability for any decisions made based on it.

By continuing to view this page, you acknowledge and agree that you are responsible for your own investment decisions.

Post-Financing NYSE Uplisting Program

Upon meeting the necessary criteria related to share price, shareholders’ equity, audited financials, and corporate governance, SINC will seek an uplisting to a national exchange, with the NYSE as its primary target.
This uplisting would allow the Company to:

  • Access a broader institutional investor base

  • Expand liquidity

  • Enhance valuation comparability

  • Elevate company visibility in global markets

This step aligns with SINC’s long-term ambition to transition from a niche materials company to a recognized participant in the global advanced materials and industrial technology sector.

Post-Financing NYSE Uplisting Program

Following completion of the private placement, SINC intends to promptly initiate the formal process of pursuing an uplisting to the New York Stock Exchange.

The anticipated uplisting program may include:

  • Engagement of the required legal, accounting and capital-markets advisers

  • Assessment of the applicable NYSE listing standard

  • Completion of audited financial statements and required disclosures

  • Evaluation of capitalization, shareholder-equity and market-value requirements

  • Corporate-governance and independent-director preparation

  • Preparation and submission of the applicable listing application

  • Completion of any required registration, regulatory review and exchange review

Completion of the financing is intended to provide SINC with the capital base necessary to commercialize SpectroVera and begin pursuing the applicable financial, governance and regulatory requirements for an NYSE listing.

An NYSE uplisting is subject to SINC satisfying the applicable listing standards, regulatory requirements and exchange review. There can be no assurance regarding whether or when an uplisting will be completed.

Request Investment Information

Investors interested in supporting the commercialization of SpectroVera and SINC’s post-financing NYSE uplisting strategy may submit preliminary information through the form below.

After reviewing an inquiry, SINC may provide eligible prospective investors with the appropriate confidential materials for either the Regulation D or Regulation S pathway.

Submission of the form does not constitute an investment, an offer, acceptance by SINC, confirmation of investor eligibility or assurance that offering materials will be provided.

Important Notice

This page is provided solely for preliminary informational and investor-inquiry purposes. It does not constitute an offer to sell or a solicitation of an offer to buy any security. Any offer or sale will be made only through definitive offering and subscription documents, to persons satisfying applicable eligibility requirements, and in compliance with applicable securities laws.

The proposed financing terms, use of proceeds and capital-markets plans described above are preliminary and subject to change. No securities may be purchased through this webpage, and no funds should be sent in response to this webpage.

Securities issued through a private placement may be restricted securities, may not be freely transferable and may involve a high degree of risk. The completion of the proposed financing does not assure that SpectroVera will achieve commercialization, that SINC will satisfy NYSE listing standards or that an NYSE uplisting will be completed.

Prospective investors should review the definitive offering materials and consult their own legal, tax and financial advisers before making an investment decision.

Request Investment Information

Submit your preliminary information to request access to the appropriate SINC private placement materials

SincerityApplied Material Science

To be the most creative, respectable and responsible leader in material science

Contact

info@sincnano.com

+61 4 2100 7277

© 2025. All rights reserved.

Level 2, 627 Chapel St, South Yarra, VIC, 3141, Australia